Literature DB >> 22279938

Crosstalk between RXR, LXR and VDR within blood mononuclear cellular model.

Vivek P Dave1, Deepak Kaul, Monika Sharma.   

Abstract

An accumulation of data from in vitro to in vivo model system has established a pivotal role of three crucial ligand activated nuclear receptors RXR, LXR-alpha and VDR for their ability to regulate an array of genes involved in regulation of fundamental cellular processes to patho-physiological situations. Keeping in view RXR as a common heterodimeric partner for LXR-alpha and VDR, the present study was designed to dissect the interrelationship between these three nuclear receptors in peripheral blood mononuclear cellular model. The present study revealed that all the three nuclear receptors displayed auto regulation in response to their specific ligands; Both LXR-alpha and VDR regulated the expression of their heterodimeric partner RXR; and VDR was regulated by LXR-alpha through its ability to modulate SREBP response element present in the promoter region of VDR gene. Based on these findings, the role of these nuclear receptors could be better understood in various nuclear receptor mediated pathological processes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22279938

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  2 in total

1.  Vitamin D Protects Against Atherosclerosis via Regulation of Cholesterol Efflux and Macrophage Polarization in Hypercholesterolemic Swine.

Authors:  Kai Yin; Yong You; Vicki Swier; Lin Tang; Mohamed M Radwan; Amit N Pandya; Devendra K Agrawal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-09-17       Impact factor: 8.311

2.  Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelination.

Authors:  Muktha S Natrajan; Alerie G de la Fuente; Abbe H Crawford; Eimear Linehan; Vanessa Nuñez; Kory R Johnson; Tianxia Wu; Denise C Fitzgerald; Mercedes Ricote; Bibiana Bielekova; Robin J M Franklin
Journal:  Brain       Date:  2015-10-12       Impact factor: 13.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.